Amgen continues to target mid-December deadline for Horizon deal close

Amgen and Horizon continue to target a mid-December close for their $28 billion merger, though a court order temporarily blocking the deal has been extended now that a hearing date has been set.

A temporary restraining order preventing the companies from closing the deal has been extended to Oct. 31,…